OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery and Validation of Clinical Biomarkers of Cancer: A Review Combining Metabolomics and Proteomics
Anubhav Srivastava, Darren J. Creek
PROTEOMICS (2018) Vol. 19, Iss. 10
Closed Access | Times Cited: 93

Showing 1-25 of 93 citing articles:

Fluorescence sensing and imaging with carbon-based quantum dots for early diagnosis of cancer: A review
Rashin Mohammadi, Hossein Naderi‐Manesh, Leila Farzin, et al.
Journal of Pharmaceutical and Biomedical Analysis (2022) Vol. 212, pp. 114628-114628
Closed Access | Times Cited: 101

Carbon nanomaterials-based electrochemical aptasensor for point-of-care diagnostics of cancer biomarkers
Arpana Parihar, Nishant Kumar Choudhary, Palak Sharma, et al.
Materials Today Chemistry (2023) Vol. 30, pp. 101499-101499
Closed Access | Times Cited: 44

Blueprint for cancer research: Critical gaps and opportunities
Lynne W. Elmore, Susanna F. Greer, Elvan C. Daniels, et al.
CA A Cancer Journal for Clinicians (2020) Vol. 71, Iss. 2, pp. 107-139
Open Access | Times Cited: 87

Recent Metabolomics Analysis in Tumor Metabolism Reprogramming
Jingjing Han, Qian Li, Yu Chen, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 58

Clinical applications of mass spectrometry‐based proteomics in cancer: Where are we?
Emma L. Boys, Jia Liu, Phillip J. Robinson, et al.
PROTEOMICS (2022) Vol. 23, Iss. 7-8
Open Access | Times Cited: 38

Incorporating Novel Technologies in Precision Oncology for Colorectal Cancer: Advancing Personalized Medicine
Pankaj Ahluwalia, Kalyani Ballur, Tiffanie Leeman, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 480-480
Open Access | Times Cited: 13

Odors and cancer: Current status and future directions
Flora Gouzerh, Jean‐Marie Bessière, Beáta Újvári, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1877, Iss. 1, pp. 188644-188644
Open Access | Times Cited: 48

Annexin A5 as a targeting agent for cancer treatment
Alexis Woodward, Gabriela N. F. Faria, Roger G. Harrison
Cancer Letters (2022) Vol. 547, pp. 215857-215857
Closed Access | Times Cited: 29

Small molecule biomarker discovery: Proposed workflow for LC-MS-based clinical research projects
Samuel Rischke, Lisa Hahnefeld, Bo Burla, et al.
Journal of Mass Spectrometry and Advances in the Clinical Lab (2023) Vol. 28, pp. 47-55
Open Access | Times Cited: 19

Metabolomics Contributions to the Discovery of Prostate Cancer Biomarkers
Nuria Gómez-Cebrián, Ayelén Rojas‐Benedicto, Arturo Albors-Vaquer, et al.
Metabolites (2019) Vol. 9, Iss. 3, pp. 48-48
Open Access | Times Cited: 52

Efficient Sample Preparation System for Multi-Omics Analysis via Single Cell Mass Spectrometry
Peng Zhao, Yongxiang Feng, Junhan Wu, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 18, pp. 7212-7219
Closed Access | Times Cited: 15

Integrated models of blood protein and metabolite enhance the diagnostic accuracy for Non-Small Cell Lung Cancer
Runhao Xu, Jiongran Wang, Qingqing Zhu, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 13

Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivity
Alexander Arthur Wurm, Silke Brilloff, Sofia Kolovich, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 10, pp. 101200-101200
Open Access | Times Cited: 13

Therapeutic Efficacy Studies on the Monoterpenoid Hinokitiol in the Treatment of Different Types of Cancer
Md. Shimul Bhuia, Raihan Chowdhury, Meher Afroz, et al.
Chemistry & Biodiversity (2025)
Closed Access

A review on proteomic and genomic biomarkers for gelatin source authentication: Challenges and future outlook
Marco García‐Vaquero, Armin Mirzapour‐Kouhdasht
Heliyon (2023) Vol. 9, Iss. 6, pp. e16621-e16621
Open Access | Times Cited: 9

Dietary patterns, untargeted metabolite profiles and their association with colorectal cancer risk
Stina Bodén, Rui Zheng, Anton Ribbenstedt, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3

An Innovative Approach for Tailoring Molecularly Imprinted Polymers for Biosensors—Application to Cancer Antigen 15-3
Daniela Oliveira, Andreia S. R. Oliveira, Patrícia V. Mendonça, et al.
Biosensors (2024) Vol. 14, Iss. 5, pp. 222-222
Open Access | Times Cited: 3

Active repurposing of drug candidates for melanoma based on GWAS, PheWAS and a wide range of omics data
Ali Khosravi, B. Jayaram, Bahram Goliaei, et al.
Molecular Medicine (2019) Vol. 25, Iss. 1
Open Access | Times Cited: 26

Screening of Potential Biomarkers for Gastric Cancer with Diagnostic Value Using Label-Free Global Proteome Analysis
Yongxi Song, Jun Wang, Jingxu Sun, et al.
Genomics Proteomics & Bioinformatics (2020) Vol. 18, Iss. 6, pp. 679-695
Open Access | Times Cited: 24

Sweat metabolome and proteome: Recent trends in analytical advances and potential biological functions
Ahmed Serag, Zaynab Shakkour, Abdulsalam Halboup, et al.
Journal of Proteomics (2021) Vol. 246, pp. 104310-104310
Closed Access | Times Cited: 22

Discovering Panel of Autoantibodies for Early Detection of Lung Cancer Based on Focused Protein Array
Di Jiang, Xue Zhang, Man Liu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 21

Mucins as contrast agent targets for fluorescence-guided surgery of pancreatic cancer
Kathryn M. Muilenburg, Carly C. Isder, Prakash Radhakrishnan, et al.
Cancer Letters (2023) Vol. 561, pp. 216150-216150
Open Access | Times Cited: 8

Page 1 - Next Page

Scroll to top